Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

INTRODUCTION: The biological pathways involved in the preclinical stage of the Alzheimer's continuum are not well understood. METHODS: We used NeuroToolKit and Elecsys(®) immunoassays to measure cerebrospinal fluid (CSF) amyloid‐β (Aβ)42, Aβ40, phosphorylated tau (p‐tau), total tau (t‐tau), neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Milà‐Alomà, Marta, Salvadó, Gemma, Gispert, Juan Domingo, Vilor‐Tejedor, Natalia, Grau‐Rivera, Oriol, Sala‐Vila, Aleix, Sánchez‐Benavides, Gonzalo, Arenaza‐Urquijo, Eider M., Crous‐Bou, Marta, González‐de‐Echávarri, José Maria, Minguillon, Carolina, Fauria, Karine, Simon, Maryline, Kollmorgen, Gwendlyn, Zetterberg, Henrik, Blennow, Kaj, Suárez‐Calvet, Marc, Molinuevo, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586814/
https://www.ncbi.nlm.nih.gov/pubmed/32573951
http://dx.doi.org/10.1002/alz.12131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586814/
https://www.ncbi.nlm.nih.gov/pubmed/32573951
http://dx.doi.org/10.1002/alz.12131

Ejemplares similares